Professor of Clinical Genetics, University Wash

Internal Medicine

Dr. Wylie G. Burke, MD

Wylie Burke practices Internal Medicine. She attended University of Washington School of Medicine. Dr. Wylie G. Burke is a published doctor and has 45 publications published. The lastest was: 'Hemochromatosis: genetics helps to define a multifactorial disease.'

Publications

Community crystal gazing.
Patients' Choices for Return of Exome Sequencing Results to Relatives in the Event of Their Death.
Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide.
Design, implementation, and first-year outcomes of a value-based drug formulary.
Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas.
Closing the Gap between Knowledge and Clinical Application: Challenges for Genomic Translation.
The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.
Effects of web-based intervention on risk reduction behaviors in melanoma survivors.
A Call for Accurate Pharmacogenetic Labeling: Telling It Like It Is.
Regulatory changes raise troubling questions for genomic testing.
Comparative effectiveness of next generation genomic sequencing for disease diagnosis: Design of a randomized controlled trial in patients with colorectal cancer/polyp...
Pharmacogenetic research in partnership with American Indian and Alaska Native communities.
The translational potential of research on the ethical, legal, and social implications of genomics.
Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between.
Exploring pathways to trust: a tribal perspective on data sharing.
Essential elements of personalized medicine.
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Researc...
Eugenics to medical genetics.
Risk, Reward, and the Double-Edged Sword: Perspectives on Pharmacogenetic Research and Clinical Testing Among Alaska Native People.
Actionable, Pathogenic Incidental Findings in 1,000 Participants' Exomes.
Trends in death associated with pediatric dental sedation and general anesthesia.
Recommendations for returning genomic incidental findings? We need to talk!
Primary-care physicians' access to genetic specialists: anÃ‚Â impediment to the routine use of genomic medicine?
Return of incidental findings in genomic medicine: measuring what patients value-development of an instrument to measure preferences for information from next-generati...
Return of incidental findings in genomic medicine: measuring what patients value.
Building Partnerships in Community-Based Participatory Research: Budgetary and Other Cost Considerations.
Managing incidental genomic findings: legal obligations of clinicians.
Informed Consent in Genome-Scale Research: What Do Prospective Participants Think?
Finding a place for genomics in health disparities research.
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network.
WHAT DNA CAN AND CANNOT SAY: PERSPECTIVES OF IMMIGRANT FAMILIES ABOUT THE USE OF GENETIC TESTING IN IMMIGRATION.
Genetic tests: clinical validity and clinical utility.
Incorporation of purine nucleosides in cultured fibroblasts from a patient with purine nucleoside phosphorylase deficiency and associated T-cell immunodeficiency.
Rhabdomyolysis associated with lovastatin and erythromycin use.
Do we still need primary care tracks?
Researcher perspectives on disclosure of incidental findings in genetic research.
Clinical validity and clinical utility of genetic tests.
Practicing moral medicine: patient care to public health.
Gene expression profiling and breast cancer care: what are the potential benefits and policy implications?
Genetics in primary care: a USA faculty development initiative.
Genetic test evaluation: information needs of clinicians, policy makers, and the public.
Hemochromatosis: genetics helps to define a multifactorial disease.
Patient safety in genomic medicine: an exploratory study.

Schools

University of Washington
University Wa Med Center

Doctors Specialties

Internal Medicine

Accepted Insurances

Education

University of Washington School of Medicine

Hospital

University of Washington Medical Center

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Kamala B. Jain, MD This Doctor is OpenDoctor Recommended.
	Dr. Kathryn L. Maxwell, DO
	Dr. Tyra L. Fainstad, MD This Doctor is OpenDoctor Recommended.
	Dr. Angela G. Heithaus, MD This Doctor is OpenDoctor Recommended.
	Dr. Scott L. Hagan, MD